drugset / Trial / NCT05398055

Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever

NCT05398055

Phase 3 Unknown 86 enrolled Hospital General de Mexicali
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to impove the pharmacological treatment of Rocky mountain spotted fever, since is a very ancient disease with an antibiotic therapy that have not changed much the mortality rates, being compared with the natural curse of the disease.

Timeline

Start
2022-05-12
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 500 mg Oral
Background Doxycycline Small molecule 100 mg Oral